- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/92 - Nitro radicals attached in position 4 or 5
Patent holdings for IPC class C07D 233/92
Total number of patents in this class: 28
10-year publication summary
|
2
|
2
|
4
|
1
|
2
|
1
|
2
|
0
|
0
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 1010 |
3 |
| Otsuka Pharmaceutical Co., Ltd. | 1504 |
3 |
| Dynamit Nobel GmbH Explosivstoff-und Systemtechnik | 13 |
2 |
| Bayer Cropscience AG | 1878 |
1 |
| Murata Manufacturing Co., Ltd. | 25590 |
1 |
| Board of Regents, The University of Texas System | 6065 |
1 |
| The Trustees of the University of Pennsylvania | 4403 |
1 |
| National Institute of Advanced Industrial Science and Technology | 3794 |
1 |
| Asahi Kasei Chemicals Corporation | 567 |
1 |
| Eli Lilly and Company | 4050 |
1 |
| Eth Zurich | 1316 |
1 |
| Fudan University | 748 |
1 |
| Immunomet Therapeutics Inc. | 31 |
1 |
| Nanjing Sanhome Pharmaceutical Co., Ltd. | 62 |
1 |
| New Form Pharmaceuticals Inc. | 1 |
1 |
| Nippon Soda Co., Ltd. | 883 |
1 |
| Shikoku Chemicals Corporation | 101 |
1 |
| St. Jude Children's Research Hospital, Inc. | 240 |
1 |
| Taiyo Nippon Sanso Corporation | 367 |
1 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2980 |
1 |
| Other owners | 3 |